Results 211 to 220 of about 51,762 (264)
Some of the next articles are maybe not open access.
The Effect of Local Vasodilating Agents
1977Contrary to the previously widely held concept that nitroglycerin is contraindicated in acute myocardial infarction, it has recently been shown that the administration of nitroglycerin to patients with acute myocardial infarction and elevated left ventricular filling pressures results in a reduction in filling pressure and in an increase in cardiac ...
openaire +2 more sources
Vasodilators (Other Agents and Drug Classes)
2000In addition to the angiotensin II receptor blockers, the angiotensin converting enzyme inhibitors, and the calcium channel blockers, which are discussed in other chapters, there are other peripheral vasodilators that include a wide variety of compounds with highly disparate mechanisms of action.
William H. Frishman +2 more
openaire +1 more source
Chapter 8. Vasodilator and Vasoconstrictor Agents
1969Publisher Summary This chapter presents an overview of vasodilator and vasoconstrictor agents. Many drugs with diverse pharmacological actions ultimately alter vascular tone. Antihypertensive agents as well as drugs used to treat peripheral vascular diseases are among those that reduce vascular tone.
F.P. Hauck, C.N. Gillis
openaire +1 more source
Vasodilator agents protect against indinavir nephrotoxicity.
Antiviral therapy, 2004Indinavir (IDV) is a protease inhibitor widely used in AIDS treatment. A sustained elevation of creatinine was identified in IDV-treated patients. We have previously demonstrated that IDV causes renal vasoconstriction in rats. The objective of this study was to investigate the mechanism of IDV-induced vasoconstriction and the effect that the ...
Mogali, de Araujo +1 more
openaire +1 more source
Mechanism of Action of Vasodilating Agents
1988The development of heart failure is accompanied by the activation of neuroendocrine compensatory mechanisms (see chapter “Endocrine response to heart failure”). Although these responses are initially aimed at preserving cardiovascular homeostasis, they eventually lead to a further deterioration of myocardial performance due to excessive ...
J. Biollaz, A. Munafo, T. Buclin
openaire +1 more source
[Vasodilator agents and the vascular endothelium].
Annales de cardiologie et d'angeiologie, 1990The recent discovery of endothelium-derived relaxation factor (EDRF) has altered the traditional classification of vasodilators used in angina pectoris and heart failure. If a vasodilator induces release of EDRF from the epithelium it is classified as endothelium-dependent, if not it is independent.
openaire +1 more source
Vasodilators and hypotensive agents
1996R F Armstrong, W Aveling, E M Grundy
openaire +1 more source
Some therapeutic applications of vasodilating agents
The American Journal of Medicine, 1953openaire +2 more sources
Pentoxifylline, Vasodilators, and Metabolic Agents
2003Samuel Money, W SternbeghIII
openaire +2 more sources

